About this item:

381 Views | 622 Downloads

Author Notes:

Corresponding author at: 720 Westview Drive SW, Atlanta, GA 30310, USA

Authors would like to thank Natalia Kozyk, PhD, for her work on microarray testing, Frederick Bright, MD, for the intraoperative photograph and the medical oncology team under Myra Rose, MD for chemotherapy care of the patient.

The authors have no conflicts of interest to declare.

Subjects:

Keywords:

  • Chemotherapy
  • Human chorionic gonadotropin

Endometrial carcinoma with ectopic human chorionic gonadotropin expression

Tools:

Journal Title:

Gynecologic Oncology Reports

Volume:

Volume 12

Publisher:

, Pages 45-48

Type of Work:

Article | Final Publisher PDF

Abstract:

Aggressive course and treatment resistance characterize ectopic human chorionic gonadotropin. Recurrence of endometrial cancer with ectopic hCG was treated with brachytherapy and EMACO. The serum hCG level can serve as a marker in tumors with ectopic hCG expression.

Copyright information:

© 2015 The Authors

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Creative Commons License

Export to EndNote